Acacia Research (ACTG)
(Delayed Data from NSDQ)
$5.28 USD
+0.05 (0.96%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $5.28 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Acacia Research Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 440 | 386 | 707 | 451 | 168 |
Receivables | 81 | 8 | 10 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 11 | 14 | 9 | 0 | 0 |
Other Current Assets | 23 | 19 | 5 | 6 | 3 |
Total Current Assets | 555 | 428 | 731 | 458 | 172 |
Net Property & Equipment | 27 | 4 | 4 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 2 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 3 | 0 | 0 | 0 | 0 |
Intangibles | 43 | 44 | 56 | 17 | 8 |
Deposits & Other Assets | 4 | 5 | 6 | 40 | 36 |
Total Assets | 634 | 483 | 799 | 516 | 218 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 60 | 181 | 116 | 0 |
Accounts Payable | 3 | 6 | 5 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 13 | 19 | 10 | 6 | 8 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 12 | 2 | 4 | 2 | 2 |
Total Current Liabilities | 28 | 87 | 200 | 125 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 1 | 19 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 11 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 103 | 132 | 86 | 22 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 44 | 194 | 354 | 212 | 35 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 20 | 15 | 11 | 8 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 906 | 663 | 648 | 651 | 652 |
Retained Earnings | -240 | -307 | -182 | -327 | -440 |
Other Equity | 21 | 11 | 11 | 11 | 2 |
Treasury Stock | 98 | 98 | 47 | 43 | 39 |
Total Shareholder's Equity | 590 | 289 | 445 | 303 | 183 |
Total Liabilities & Shareholder's Equity | 634 | 483 | 799 | 516 | 218 |
Total Common Equity | 590 | 269 | 430 | 293 | 175 |
Shares Outstanding | 99.80 | 43.40 | 49.50 | 49.20 | 50.30 |
Book Value Per Share | 5.91 | 6.21 | 8.70 | 5.95 | 3.48 |
Fiscal Year End for Acacia Research Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 440 | 446 | 445 | 462 | 386 |
Receivables | 81 | 6 | 6 | 9 | 8 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 11 | 12 | 14 | 15 | 14 |
Other Current Assets | 23 | 20 | 21 | 20 | 19 |
Total Current Assets | 555 | 484 | 486 | 505 | 428 |
Net Property & Equipment | 27 | 3 | 3 | 3 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 3 | 0 | 0 | 0 | 0 |
Intangibles | 43 | 35 | 38 | 41 | 44 |
Deposits & Other Assets | 4 | 5 | 7 | 5 | 5 |
Total Assets | 634 | 529 | 535 | 557 | 483 |
Liabilities & Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 60 | 61 | 60 |
Accounts Payable | 3 | 9 | 6 | 8 | 6 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 13 | 10 | 10 | 18 | 19 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 12 | 2 | 2 | 2 | 2 |
Total Current Liabilities | 28 | 21 | 78 | 90 | 87 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 1 | 1 | 1 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 11 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 97 | 87 | 103 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 44 | 26 | 176 | 179 | 194 |
Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 23 | 21 | 20 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 906 | 905 | 739 | 740 | 663 |
Retained Earnings | -240 | -314 | -316 | -297 | -307 |
Other Equity | 21 | 11 | 11 | 11 | 11 |
Treasury Stock | 98 | 98 | 98 | 98 | 98 |
Total Shareholder's Equity | 590 | 504 | 359 | 377 | 289 |
Total Liabilities & Shareholder's Equity | 634 | 529 | 535 | 557 | 483 |
Total Common Equity | 590 | 504 | 335 | 356 | 269 |
Shares Outstanding | 99.80 | 99.80 | 58.70 | 58.50 | 43.40 |
Book Value Per Share | 5.91 | 5.05 | 5.71 | 6.08 | 6.21 |